KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Lacosamide is indicated to treat partial-onset seizures
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Subscribe To Our Newsletter & Stay Updated
